Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids)
Patents for A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids) (127,169)
10/2002
10/10/2002US20020147161 Novel antisense inhibition of rad51
10/10/2002US20020146759 Stress proteins and peptides and methods of use thereof
10/10/2002US20020146473 High temperature solvent extraction of echinacea plant extracts; drying to form powders, then compressing with excipients to form tablets; efficiency
10/10/2002US20020146417 Administering function blocking antibody or a fragment antibody, capable of binding an epitope of VLA-1 to provide a decrease in arthritic score of about 65% or greater when compared to control antibody treated subject
10/10/2002US20020146416 Human trk receptors and neurotrophic factor inhibitors
10/10/2002DE10117183A1 Verwendung von substituierten Imidazo[1,2-a]-pyridinverbindungen als Arzneimittel Use of substituted imidazo [1,2-a] -pyridinverbindungen as medicaments
10/10/2002DE10115310A1 Bakteriophagen-Präparation Bacteriophage preparation
10/10/2002DE10114775A1 2-Mercapto-4,5-diarylimidazolderivate und ihre Verwendung in der Pharmazie 2-mercapto-4,5-diarylimidazolderivate and their use in the pharmaceutical
10/10/2002DE10111165A1 Verwendung von Hyaluronsäure-Uroniden zur Behandlung von entzündlichen Vorgängen Use of hyaluronic acid for treating inflammatory processes Uroniden
10/10/2002CA2455915A1 Methods and compositions for using mhc class ii invariant chain polypeptide as a receptor for macrophage migration inhibitory factor
10/10/2002CA2443050A1 Immunomodulation and effect on cell processes relating to serotonin family receptors
10/10/2002CA2442798A1 Antioxidant nitroxides and nitrones as therapeutic agents
10/10/2002CA2442684A1 Control of growth and repair of gastro-intestinal tissues by gastrokines and inhibitors
10/10/2002CA2442525A1 Cyclopropylindole derivatives as selective serotonin reuptake inhibitors
10/10/2002CA2442495A1 Alpha conotoxin peptides with analgesic properties
10/10/2002CA2442484A1 Cyano-substituted dihydropyrimidine compounds and their use to treat diseases
10/10/2002CA2442457A1 Carbon monoxide generating compounds for treatment of vascular, inflammatory and immune disorders
10/10/2002CA2442354A1 New pyrimidine-2,4,6-trione derivatives, processes for their production and pharmaceutical agents containing these compounds
10/10/2002CA2442328A1 Therapeutic combinations for cardiovascular and inflammatory indications
10/10/2002CA2442146A1 Formulations comprising entrapped active ingredients and uses thereof
10/10/2002CA2442064A1 G-protein coupled receptors
10/10/2002CA2442062A1 Secreted proteins
10/10/2002CA2441970A1 Guanylate cyclase receptor agonists for the treatment of tissue inflammation and carcinogenesis
10/10/2002CA2441252A1 Estrogen replacement therapy
10/10/2002CA2441077A1 Substituted carbazoles as inhibitors of spla2
10/10/2002CA2440831A1 Combination therapy using cd40 and cd20 ligands
10/10/2002CA2439842A1 Gaba-receptor modulators for the treatment of neurodegenerative diseases of the eye
10/10/2002CA2438272A1 Compounds useful as modulators of melanocortin receptors and pharmaceutical compositions comprising same
10/10/2002CA2429265A1 Mammalian alpha-helical protein-53
10/09/2002EP1247865A2 Antibody for use in therapy
10/09/2002EP1247810A1 Novel benzotriazoles anti-inflammatory compounds
10/09/2002EP1247527A1 Cosmetic and/or pharmaceutical preparations containing extracts of the plant Litchi chinensis Sonn
10/09/2002EP1246925A1 Di- or oligomer of a dimer, trimer, quatromer or pentamer of recombinant fusion proteins
10/09/2002EP1246918A2 Secreted proteins
10/09/2002EP1246846A2 Soluble interleukin-20 receptor
10/09/2002EP1246844A1 Interleukin-1 receptor antagonist-related molecules and uses thereof
10/09/2002EP1246842A1 Nk cell receptor polynucleotides, polypeptides, and antibodies
10/09/2002EP1246840A2 Human and parasite orphan receptor proteins
10/09/2002EP1246839A1 Depsipeptide and congeners thereof for use as immunosuppressants
10/09/2002EP1246825A1 Fused pyrrole compounds, pharmaceutical agents containing the same, and the use thereof
10/09/2002EP1246824A1 Carboxamide diazepin derivatives, preparation method, use as medicines, pharmaceutical compositions and use thereof
10/09/2002EP1246823A1 Pyrimidine and triazine kinase inhibitors
10/09/2002EP1246809A1 5-aryl-1h-1,2,4-triazole compounds as inhibitors of cyclooxygenase-2 and pharmaceutical compositions containing them
10/09/2002EP1246808A1 1,2-diaryl benzimidazoles for treating illnesses associated with a microglia activation
10/09/2002EP1246807A2 Novel hydantoin, thiohydantoin, pyrimidinedione and thioxopyrimidinone derivatives, preparation method and use as medicines
10/09/2002EP1246800A1 Beta-amino acid compounds as integrin antagonists
10/09/2002EP1246799A1 Substituted pyrrole mannich bases to combat pain and allergic reactions
10/09/2002EP1246793A2 Substituted aminomethyl-phenyl-cyclohexane derivatives
10/09/2002EP1246791A2 Aminomethyl-phenyl-cyclohexanone derivatives
10/09/2002EP1246790A1 Substituted 1 and 2 naphthol mannich bases
10/09/2002EP1246630A1 Compositions and methods for facilitating skin growth and managing skin conditions
10/09/2002EP1246629A1 Methods of using electron active compounds for managing cancer
10/09/2002EP1246625A2 Methods and compositions for mitigating pain using nitrate esters
10/09/2002EP1246621A1 Nitrosated and nitrosylated cyclooxygenase-2 inhibitors, compositions and methods of use
10/09/2002EP1246620A1 Substituted acylhydroxamic acids and method of reducing tnf-g(a) levels
10/09/2002EP1246619A1 Urotensin-ii receptor antagonists
10/09/2002EP1246616A1 Cell permeable peptides for inhibition of inflammatory reactions and methods of use
10/09/2002EP1246538A1 Thickened oil compositions of edible oil
10/09/2002EP1066029B1 Peroral active agent suspension
10/09/2002EP1049467B1 Celecoxib compositions
10/09/2002EP0973550B1 Antagonistic anti-avb3 integrin antibodies
10/09/2002EP0964856B1 Bicyclic amino acids
10/09/2002EP0904061B1 Pharmaceutical composition with base of rhein or diacerhein with improved biological availability
10/09/2002EP0769025B1 Diagnostic methods and compositions relating to the proteoglycan proteins of cartilage breakdown
10/09/2002CN1373774A Compositions isolated from skin cells and methods for their use
10/09/2002CN1373763A Pteridinones and kinase inhibitors
10/09/2002CN1373755A Azacycloalkanone serine protease inhibitors
10/09/2002CN1373751A 'Alpha'-amino-'beta'-sulfonyl hydroxamic acid compounds
10/09/2002CN1373745A 3-amino-2-benzyl-1-phenyl-propane derivs.
10/09/2002CN1373660A Method for treating chronic pain using MEK inhibitors
10/09/2002CN1373202A Rheumatism-resistant Yikang liquor
10/09/2002CN1373126A Crystallization formed N-(4-trifluoromethylphenyl)-5-methyl isooxazo-4-carboxamide
10/09/2002CN1372969A Medical liquor for treating rheuamtic arthritis ischias, etc
10/09/2002CN1372961A Plaster and its preparing process
10/09/2002CN1372959A Process for preparing patch 'Jingubitong'
10/09/2002CN1372948A Exterior-applied liquid medicine for promoting blood circulation, dispelling exogenous factor of wind and relaxing pain
10/09/2002CN1372943A Medicine for treating rheumatoid and rheumatic arthritis by particular acupoint therapy
10/09/2002CN1372922A Multilayer emulsion for stabilization of effective component on dermatology and externally used preparation using it
10/09/2002CN1092066C Analgesic plaster for osteoarthritis
10/09/2002CN1092056C Chinese medicine 'Kaibitong' for treating rheumatism
10/09/2002CN1092049C Composition for treating late allergic reactions and inflammation diseases, and use thereof
10/08/2002US6462078 Antiinflammatory agents; library of plant extracts
10/08/2002US6462067 Administering histamine or salt derivative; preventing and/or reducing oxidative cellular and tissue damage; inflammatory diseases, including rheumatoid arthritis, crohn's disease, and adult respiratory distress syndrome
10/08/2002US6462065 Use of 5-HT3 receptor antagonists for treating musculoeskeletal diseases
10/08/2002US6462060 Heterocyclic-hydroxyimino-fluorene nuclei compounds and pharmaceutical compositions for inhibiting protein kinases, and methods for their use
10/08/2002US6462047 Containing 5- or 6-membered oxygen, nitrogen and/or sulfur heteroaryl group; angina, hypertension, respiratory distress, congestive heart failure, renal failure, atherosclerosis, inflammatory diseases, strokes, bronchitis, asthma
10/08/2002US6462036 Inhibiting signal transduction by modulating activity of receptor and nonreceptor tyrosine and serine/threonine kinases to regulate and modulate abnormal or inappropriate cell proliferation, differentiation, or metabolism
10/08/2002US6462020 N-formyl-met-leu-leu-phe-phe; inhibiting release of cytokines, histamines and leukotrienes; reducing adhesion, migration and aggregation of lymphocytes, eosinophils and neutrophils; rheumatoid arthritis
10/08/2002US6461846 Peptide for use in the treatment of alzhiemer's, inflammation, cancer and immune defects
10/08/2002US6461822 Therapeutic targets for agents that suppress the release of inflammatory mediators such as interleukin il-1 and il-1 beta
10/08/2002US6461642 Crystallization using supercritical or subcritical fluids
10/08/2002US6461602 Water-soluble, nontoxic prodrugs having a hydrolyzable carbamate group coupling the drug or active ingredient to a modified polymer; insoluble drug released in vivo; drug delivery
10/08/2002CA2252982C Substituted indazole derivatives and their use as inhibitors phosphodiesterase (pde) type iv and the production of tumor necrosis factor (tnf)
10/08/2002CA2231046C Human protein kinases hyak3
10/08/2002CA2196769C Benzimidazole derivatives having dopaminergic activity
10/08/2002CA2182486C Cyclic neurokinin a antagonists
10/08/2002CA2145775C 1,4-disubstituted piperazines useful in the therapy of the asthma and of the inflammation of the respiratory tract
10/08/2002CA2081766C Leukotriene b4 antagonists
10/04/2002CA2342708A1 Methods for inhibiting cancer growth, reducing infection and promoting general health with a fermented soy extract
10/03/2002WO2002077226A1 Prostaglandin ep1 receptor
1 ... 901 902 903 904 905 906 907 908 909 910 911 912 913 914 915 916 917 918 919 920 921 ... 1272